FOLD Q4 2021 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$82M+16.4% YoY

Gross Profit

$74M90.4% margin

Operating Income

-$72M-87.8% margin

Net Income

-$83M-101.4% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

+3.3%

Cash Flow

Operating Cash Flow

-$71M

Free Cash Flow

-$72M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$905M

Total Liabilities

$598M

Stockholders' Equity

$307M

Cash & Equivalents

$245M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$71M	+16.4%
Gross Profit	$74M	$61M	+21.5%
Operating Income	-$72M	-$65M	-11.3%
Net Income	-$83M	-$71M	-16.6%

Geographic Segments

Non-US

$57M69%

UNITED STATES

$25M31%